Mackintosh John A, Marshall Henry M, Yang Ian A, Bowman Rayleen V, Fong Kwun M
Department of Thoracic Medicine, The Prince Charles Hospital, University of Queensland, Brisbane, Queensland, Australia.
Respirology. 2014 Jul;19(5):755-62. doi: 10.1111/resp.12311. Epub 2014 May 6.
Volume doubling time (VDT) contributes to the evaluation of the indeterminate pulmonary nodule, an increasingly frequent problem given the rising use of computed tomography (CT). We aimed to correlate patient and tumour characteristics with VDT and growth rates of primary non-small cell lung cancers (NSCLC).
Surgically treated NSCLC, which underwent two or more CT scans separated by 25 or more days were studied. Tumour volume was measured using semi-automated volumetric software. VDT and growth rate (1/VDT) were correlated with patient and tumour characteristics.
Thirty-six adenocarcinomas (AC), six squamous cell carcinoma (SCC), two large cell and two carcinoids in 46 patients had 109 eligible scans. Median VDT was 191 days (range -9435 to 2256 days); median growth rate was 0.0038 (range -0.0086 to 0.0186). Median growth rate of AC was significantly slower than SCC (0.0034 vs. 0.0103, P = 0.037). Nine AC had VDT >400 days, three of which developed distant metastases. Median growth rate of AC was faster in smokers compared with never-smokers (0.0052 vs. 0.0014, P = 0.02). Growth rate was not related to symptoms at diagnosis (P = 0.16). Less differentiated tumours tended to grow faster than more differentiated (P = 0.0038). Growth curves of 12 multi-imaged tumours conformed best with the exponential model of growth.
NSCLC growth rate appears to be highly variable and related to histological subtype and smoking history, but not the presence of symptoms at diagnosis. Significant growth may be detected in as little as 2 months in NSCLC in smokers. Relatively slow-growing AC can metastasize.
鉴于计算机断层扫描(CT)的使用日益增多,体积倍增时间(VDT)有助于对不确定肺结节进行评估,这一问题愈发常见。我们旨在将患者和肿瘤特征与原发性非小细胞肺癌(NSCLC)的VDT及生长速率相关联。
对接受手术治疗的NSCLC患者进行研究,这些患者接受了两次或更多次间隔25天或更长时间的CT扫描。使用半自动容积软件测量肿瘤体积。VDT和生长速率(1/VDT)与患者和肿瘤特征相关联。
46例患者中的36例腺癌(AC)、6例鳞状细胞癌(SCC)、2例大细胞癌和2例类癌有109次符合条件的扫描。VDT中位数为191天(范围-9435至2256天);生长速率中位数为0.0038(范围-0.0086至0.0186)。AC的生长速率中位数显著慢于SCC(0.0034对0.0103,P = 0.037)。9例AC的VDT>400天,其中3例发生远处转移。与从不吸烟者相比,吸烟者中AC的生长速率中位数更快(0.0052对0.0014,P = 0.02)。生长速率与诊断时的症状无关(P = 0.16)。分化程度较低的肿瘤往往比分化程度较高的肿瘤生长更快(P = 0.0038)。12例多次成像肿瘤的生长曲线最符合指数生长模型。
NSCLC的生长速率似乎高度可变,与组织学亚型和吸烟史有关,但与诊断时是否存在症状无关。吸烟者的NSCLC在短短2个月内可能检测到显著生长。生长相对缓慢的AC可发生转移。